Articles with "lcssc" as a keyword



Photo by onthesearchforpineapples from unsplash

THU0327 ANTIBODIES AGAINST EXTRACTABLE NUCLEAR ANTIGENS (ENA) IN SCLERODERMA ARE NOT ONLY DIAGNOSTIC AND PROGNOSTIC TOOLS, BUT PATHOGENETIC REGULATORS INDUCING A PROFIBROTIC PHENOTYPE IN CULTURED SKIN FIBROBLASTS

Sign Up to like & get
recommendations!
Published in 2019 at "Annals of the Rheumatic Diseases"

DOI: 10.1136/annrheumdis-2019-eular.3521

Abstract: Background The importance of systemic sclerosis (SSc) autoantibodies for diagnosis has become increasingly recognized, as evidence by incorporation into the 2013 ACR/EULAR clinical classification criteria (1). Clear prognostic and phenotypic associations with cutaneous subtype and… read more here.

Keywords: control; lcssc; cenp topo; topo ... See more keywords

FRI0258 CUMULATIVE INCIDENCE, SURVIVAL AND PREDICTORS OF PULMONARY HYPERTENSION IN SYSTEMIC SCLEROSIS SUBSETS: PAH IS NOT INCREASED IN LIMITED VS DIFFUSE PATIENTS BY ADJUSTED COMPETING RISK ANALYSIS

Sign Up to like & get
recommendations!
Published in 2020 at "Annals of the Rheumatic Diseases"

DOI: 10.1136/annrheumdis-2020-eular.3847

Abstract: Background: Pulmonary hypertension (PH) is a life-threatening complication of systemic sclerosis (SSc), thought to be more commonly found in limited cutaneous (lcSSc) compared to diffuse (dcSSc) subset. Since lcSSc has a better prognosis, it is… read more here.

Keywords: cumulative incidence; lcssc; incidence; systemic sclerosis ... See more keywords